India’s contract drug makers seek government support in China fight

India’s Contract Research Development and Manufacturing Organisation (CRDMO) sector is at an inflection point, with the potential to grow seven-fold to $22 billion-$25 billion by 2035, according to a report by Boston Consulting Group.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *